- Primary Antibodies
-
ELISA Kits
- Infectious Disease ELISA Kits
- Parasitology ELISA kits
- Normalization ELISA Kits
- Kidney Injury Biomarker ELISA Kits
- Human ELISA Kits
- Rat ELISA Kits
- Mouse ELISA Kits
- Bovine ELISA Kits
- Porcine Protein ELISA Kits
- Chicken Protein ELISA Kits
- Dog/Canine ELISA Kits
- Small Molecules ELISA Kits
- Monkey & other ELISA Kits
- Food ELISA Kits
- Autoimmune Disease ELISA Kits
- Cancer Biomarker ELISA Kits
- Steroids ELISA Kits
-
Proteins
- Recombinant Proteins
- Growth Factors
- Cancer
- Cardiology
- Cell structure protein
- Developmental Biology
- DNA/RNA Emyzme
- Endocrinology
- Epigenetic erasers
- Epigenetic readers
- Epigenetic writers
- Extracellular Matrix
- Gastrointestinal Diseases
- Glycobiology
- Haemetology
- Hematology
- Immunology
- Infectious disease
- Inflammation
- Metabolism
- Motorsystem
- Neuroscience
- Other
- Proteases
- Signaling Pathway
- Transcription Factor
- Ubiquitin
- Urology
- CRISPR/Cas9 Protein
- Peptides
- Reagents
-
Services
- Recombinant protein expression and purification (NB-SC101)
- Antibody Services (NB-SC102)
- ELISA Assay Development (NB-SC103)
- Antibody Pair Screening (NB-SC104)
- AlphaLisa™ and Alphascreen™ Assays (NB-SC105)
- Hybridoma Sequencing (NB-SC106)
- Development of an AlphaLisa assay for Screening Histone Methyltransferase Inhibitors (NB-SC107)
- Ultrasensitive ELISA/ ImmunoPCR (NB-SC108)
- Generation of Stable Cell Lines Expressing Antibodies (NB-SC109)
- Antibody Sequencing/ Recombinant Antibody Production (NB-SC110)
- Antibody Conjugation Services (NB-SC111)
- ELISA Testing services (NB-SC112)
- Western Blot Service (NB-SC113)
- Protocols
-
News
-
News
- Novatein Biosciences Introduces the Human Anti-Carbamylated Protein Antibody (Anti-CarP) ELISA Kit
- Launch of immunoPCR assay development and antibody-DNA conjugation services
- Novatein Biosciences launched antigen and antibodies products for the 2019-nCoV/COVIS-19/SARS-COV2 research.
- NovaTeinBio Introduce Hundreds of New ELISA Kit Products Through Their Company Catalogue
- NovaTeinBio Advancing Research with New CD Antigen Solutions
- NovaTeinBio Adds New Antibodies to Company Catalogue
- NovaTeinBio Add Protein Expression and Purification to Their Service Catalogue
- NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
- Food ELISA kits
- NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions
- Cancer Biomarker ELISA kits
- Reliable Detection of CRISPR Activity Using Cas9 Monoclonal Antibodies
- How Do Cas9 Monoclonal Antibodies Improve CRISPR Validation Accuracy?
- Why ELISA Kits Are Essential for Steroid Testing in Clinical Studies
- How to Optimize Your Workflow Using the Human CEA ELISA Kit
- Why Penicillin ELISA Kits Are Critical in Dairy Product Screening
- How Human CD161 Antibody Research Advances Immunology Insights
- OVA sIgG ELISA Kits: Measuring Immune Response Made Simple
- Why Gluten ELISA Testing Is Crucial for Celiac-Safe Products
- Why Penicillin ELISA Testing Remains Critical in Food Safety Programs
- Quantifying Human Lipoproteins in Serum Using ELISA Technology
- What Is CBX3 Antibody Used For in Epigenetics Studies?
- Canine beta NGF ELISA Kit 96T: Accurate Detection for Veterinary Research
- What's Porcine Luteinizing Hormone and How's It Used
- Best Practices for Using a CRISPR/Cas9 Host Autoantibody ELISA Kit
- How to Choose the Right Human Ovalbumin IgG ELISA Kit
- How CD161 Antibodies Help Study Immune Cell Populations
- Novatein Biosciences Launches Redesigned Website to Enhance Access to Life Science Research Products and Services
- News Letters
- Product Citations
-
News
- Distributors
-
Support
Human Hepatitis C virus IgG,HCV-IgG ELISA Kit
Catalog # NB-E10628
Assay principle
This assay employs the enzyme-linked immunosorbent assay (ELISA) technology to detect anti- Hepatitis C virus antigen (HCV) IgG in the samples. Hepatitis C virus antigen peptides were precoated in microplate wells. The anti-HCV IgG in the samples, if presents, will bind to the Hepatitis C virus antigen peptides immobilized on the wells and interacts with anti-Human IgG antibody-HRP conjugate to form an immunocomplex. Following incubation and washing procedures to remove unbound substances, this reaction is visualized by the addition of the chromogen tetramethylbenzidine (TMB). After stopping the reaction with sulfuric acid, the blue color turns yellow. What can be measured at this point is the amount of color intensity proportional to the amount of antibody captured in the wells, and to the sample.
Kit Components
1 | Microplate precoated with HCV antigens | 1x96 well |
2 | Negative Control | 0.2 ml X 1 vial |
3 | Positive Control | 0.2 ml X 1 vial |
4 | Diluent buffer | 13 mL x1 |
5 | Wash Solution (20x) | 50 mL x1 |
6 | Anti-Human IgG-HRP Conjugate | 13 ml x1 |
7 | Chromogenic Solution A | 8 ml |
8 | Chromogenic Solution B (TMB) | 8 ml |
9 | Stop Solution | 8 ml |